Sector revisions Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 225.23 USD | -0.60% |
|
+2.46% | +12.85% |
| 20/07 | Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix… |  |
| 14/07 | BofA Adjusts Price Target on Charles River Laboratories International to $264 From $220 | MT |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
 | 15 | |||||||
| 23 | |||||||
| 21 | |||||||
| 27 | |||||||
| 19 | |||||||
| 24 | |||||||
| 12 | |||||||
| - | 18 | ||||||
| 14 | |||||||
| 16 | |||||||
| 12 | |||||||
| 6 | |||||||
| 12 | |||||||
| 11 | |||||||
| 20 | |||||||
| 21 | |||||||
| 19 | |||||||
| 17 | |||||||
| 13 | |||||||
| 14 | |||||||
| Average | 17 | |||||||
| Weighted average by Cap. | 19 |
Select your edition
All financial news and data tailored to specific country editions
